Richard D. Truesdell, Jr.

Davis Polk advised the book-running manager in connection with the $156.7 million SEC-registered follow-on offering of 2,207,380 shares of Class A common stock of Hamilton Lane Incorporated…

Davis Polk advised Royalty Pharma plc in connection with its Rule 144A/Regulation S offering of $1 billion aggregate principal amount of its 0.75% senior notes due 2023, $1 billion…

Davis Polk advised the lead book-running manager and representative of the underwriters in connection with an underwritten secondary offering of 6,000,000 shares of common stock of Cal…

Davis Polk advised CureVac N.V. on its $245.3 million initial public offering of 15,333,332 of its common shares, which includes 1,999,999 common shares from the full exercise of the…

Davis Polk advised the representatives of the several underwriters in connection with the $204 million follow-on offering of 2,415,000 shares of common stock of Overstock.com, Inc.,…

Davis Polk advised the representative of the several underwriters in connection with the SEC-registered offering of 30,675,000 shares of common stock of Plug Power Inc. for approximately …

Davis Polk advised Automatic Data Processing, Inc. (“ADP”) in connection with its SEC-registered offering of $1 billion aggregate principal amount of 1.250% senior notes due 2030.  …

Davis Polk advised Freeline Therapeutics Holdings plc on its $158.8 million initial public offering of 8,823,529 American depositary shares representing 8,823,529 ordinary shares, which…

Davis Polk advised the sole book-running manager and representative of the underwriters in connection with the $59 million follow-on offering of 310,500 shares of common stock of Kinsale…

Davis Polk advised Freeport-McMoRan Inc. (“FCX”) in connection with its SEC-registered offering of $1.5 billion of senior notes. The offering consisted of $650 million of 4.375% senior…